Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29326030

Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Feb
First author
Chi KN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Feb;19(2):153-154. doi: 10.1016/S1470-2045(17)30908-7.
    note
    Source null
    related pmid
    29326027
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2018 Mar;15(3):136. doi: 10.1038/nrurol.2018.12.
    note
    Source null
    related pmid
    29384521
    relationship
    Comment in

Authors and identifiers

  1. name
    Chi KN
    type
    Author
  2. name
    Protheroe A
    type
    Author
  3. name
    Rodríguez-Antolín A
    type
    Author
  4. name
    Facchini G
    type
    Author
  5. name
    Suttman H
    type
    Author
  6. name
    Matsubara N
    type
    Author
  7. name
    Ye Z
    type
    Author
  8. name
    Keam B
    type
    Author
  9. name
    Damião R
    type
    Author
  10. name
    Li T
    type
    Author
  11. name
    McQuarrie K
    type
    Author
  12. name
    Jia B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Chi KN
    type
    Author
  2. name
    Protheroe A
    type
    Author
  3. name
    Rodríguez-Antolín A
    type
    Author
  4. name
    Facchini G
    type
    Author
  5. name
    Suttman H
    type
    Author
  6. name
    Matsubara N
    type
    Author
  7. name
    Ye Z
    type
    Author
  8. name
    Keam B
    type
    Author
  9. name
    Damião R
    type
    Author
  10. name
    Li T
    type
    Author
  11. name
    McQuarrie K
    type
    Author
  12. name
    Jia B
    type
    Author
bibliography ids
  1. nci-bib-2554a593249d69b42efb6687
book metadata
content sha256
5c967d00f3ad95a8b98e5cce66cd77a4b8e2f173a3510581af274dad77da84ab
document type
citation
dois
  1. 10.1016/S1470-2045(17)30911-7
electronic publication date
display
2018 Jan 8
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29326030
immutable id
pubmed:29326030@5c967d00f3ad95a8b98e5cce66cd77a4b8e2f173a3510581af274dad77da84ab
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
194-206
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Feb;19(2):153-154. doi: 10.1016/S1470-2045(17)30908-7.
    note
    Source null
    related pmid
    29326027
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2018 Mar;15(3):136. doi: 10.1038/nrurol.2018.12.
    note
    Source null
    related pmid
    29384521
    relationship
    Comment in
outcomes validated
false
pmid
29326030
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
869d5a80315bfcbc6e757bbbbfebf320d0f16036b42f13a222157aba7ee34c31
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Feb
precision
month
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29326030/
title
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.

Preserved source evidence · Not medical advice